Recent Related Articles
H. Mohammed et al.
The Willingness to Pay for Vaccination against Tick-Borne Encephalitis and Implications for Public Health Policy: Evidence from Sweden
by Daniel Slunge
The increasing incidence of tick-borne encephalitis (TBE) in Sweden and several other European countries has sparked a discussion about the need for a public vaccination strategy. However, TBE vaccination coverage is incomplete and there is little knowledge about the factors influencing vaccination behavior. Based on a survey of 1,500 randomly selected respondents in Sweden, we estimate vaccination coverage in areas with different TBE risk levels and analyze the role of vaccine price and other factors influencing the demand for vaccination. First, we find that the average rate of TBE vaccination in Sweden is 33% in TBE risk areas and 18% elsewhere. Income, age and risk-related factors such as incidence of TBE in the area of residence, frequency of visits to areas with TBE risk, and experience with tick bites are positively associated with demand for TBE vaccine. Next, using contingent valuation methodology, we estimate the willingness to pay for TBE vaccination among the unvaccinated respondents and the effect of a possible subsidy. Among the unvaccinated respondents in TBE risk areas, we estimate the mean willingness to pay for the recommended three doses of TBE vaccine to be 465 SEK (approximately 46 euros or 40% of the current market price). We project that a subsidy making TBE vaccines free of charge could increase the vaccination rate in TBE risk areas to around 78%, with a larger effect on low-income households, whose current vaccination rate is only 15% in risk areas. However, price is not the only factor affecting demand. We find significant effects on vaccination behavior associated with trust in vaccine recommendations, perceptions about tick bite-related health risks and knowledge about ticks and tick-borne diseases. Hence, increasing knowledge and trust, as well as ease of access to vaccinations, can also be important measures for public health agencies that want to increase the vaccination rate.The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak
E. de Wit et al.
Surveillance of Bacterial Meningitis, Ethiopia, 2012–2013
W. Mihret et al.
Rift Valley Fever Virus among Wild Ruminants, Etosha National Park, Namibia, 2011
A. Dondona et al.
Porcine Epidemic Diarrhea Virus and Discovery of a Recombinant Swine Enteric Coronavirus, Italy
M. Boniotti et al.
Severe Community-Acquired Bloodstream Infection with Acinetobacter ursingii in Person who Injects Drugs
H. Salzer et al.
Outbreak of Panton-Valentine Leukocidin–Associated Methicillin-Susceptible Staphylococcus aureus Infection in a Rugby Team, France, 2010–2011
E. Couvé-Deacon et al.
Autochthonous Nocardia cerradoensis Infection in Humans, Spain, 2011 and 2014
M. Ercibengoa et al.
Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior
I. Baussano et al.
Rapid Emergence and Clonal Dissemination of CTX-M-15–Producing Salmonella enterica Serotype Virchow, South Korea
J. Kim et al.
Seroepidemiology of Human Enterovirus 71 Infection among Children, Cambodia
P. F. Horwood et al.
New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan
T. Deguchi et al.
Initial Costs of Ebola Treatment Centers in the United States
J. J. Herstein et al.
Association between Severity of MERS-CoV Infection and Incubation Period
V. Virlogeux et al.
Absence of Middle East Respiratory Syndrome Coronavirus in Camelids, Kazakhstan, 2015
E. Miguel et al.
Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea
R. Van den Bergh et al.
Detection of Influenza D Virus among Swine and Cattle, Italy
C. Chiapponi et al.
Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease
J. R. Chancellor et al.
Epidemiology of Epidemic Ebola Virus Disease in Conakry and Surrounding Prefectures, Guinea, 2014–2015
A. Rico et al.